Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program - Wikidata - wikimedia - TriplyDB

Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program

Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program

http://www.wikidata.org/entity/Q28291559

about

sameAs

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma How I treat acquired aplastic anemia Hematopoietic stem cell transplantation for MDS.The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.High-resolution typing for unrelated donor transplantation: how far do we go?Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study Stem cells and regenerative medicine: accomplishments to date and future promise.Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.Clustering and alignment of polymorphic sequences for HLA-DRB1 genotyping Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies The research on the immuno-modulatory defect of mesenchymal stem cell from Chronic Myeloid Leukemia patients.Allogeneic transplant physician and center capacity in the United States.Leukemia stem cells: the root of chronic myeloid leukemia Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia.Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients.Molecular biological characteristics of the recruitment of hematopoietic stem cells from bone marrow niche in chronic myeloid leukemia.Haploidentical Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of Contemporaneous Matched Sibling and Unrelated Donor Transplantation for Acute Leukemia Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS).Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant.Safety of conditioning agents for allogeneic haematopoietic transplantation.Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors.Going straight to the point: intra-BM injection of hematopoietic progenitors.B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy.Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision.Myelodysplastic syndromes in the United States: an update for clinicians.Mesenchymal stem cell therapy for immune-modulation: the donor, the recipient, and the drugs in-between.Superior transplantation outcomes of 8/8-matched unrelated donors as well as matched siblings to autologous transplantation for acute myeloid leukemia with intermediate cytogenetics in first remission.Impaired immunomodulatory function of chronic myeloid leukemia cancer stem cells and the possible mechanism involved in it.Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD.Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia.Outcomes of allogeneic haemopoietic stem cell transplants at a small New Zealand centre: does size matter?Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.Current practices and supply logistics do not support HLA matching for red cell transfusions.Hypercapnia slows down proliferation and apoptosis of human bone marrow promyeloblasts.

P2860

Q24200183-D46411CB-FC6B-4465-8CF3-A63F9EFC0CA4 Q24203887-A4A8AC81-39EA-4FDD-BA01-71AA6234EEA6 Q24617687-883F0A05-AD4A-4A71-AB4D-991D5DAD31C7 Q33767314-E410C5A7-AE7A-4259-B248-DE2953F7DE73 Q33780282-E48F324E-C195-4F57-9F5F-B2CBC6368CFA Q33830964-F693ED85-0FD0-4A74-A612-206C8D519135 Q33839876-F4095390-BA7D-436F-A08D-54ED2FF5C3AC Q33999087-73C2D07C-3AE2-493C-BA81-503F6939F1D1 Q34255166-EC942498-9573-4908-9FE1-F1C2C702A578 Q34343825-8B85592F-9465-4DC4-9F35-4403F5A848BE Q34622755-2EBD156C-AC21-4D72-9689-665B70CE0C50 Q34652347-307175DB-C4A8-4F9A-AFD5-2FA3211B146C Q34749365-595F5F77-CDD3-45DB-9E51-C524F55A11C6 Q34981585-148E60C1-FE5E-4605-98A7-F6A4CE159A63 Q34984116-74493C66-3DF6-4099-B45D-9531C8996143 Q35043072-86F1C8A6-196A-43B7-B1B0-619D89AD542E Q35650523-01EFF4E5-709F-43CE-89AB-CC8FBCF8A79A Q35845470-A985C5A7-BC95-4217-8965-0F201A19F4DF Q35871747-3F1EC23C-C9E0-436E-B807-A6D6743603A1 Q35953348-6B38E64D-D339-4273-B49D-B5518D6585E5 Q36166896-61079F46-2196-4750-9F26-73F562FF1711 Q36375170-046F1741-0C86-47D1-BF1A-4F7B72FF3B6C Q36822659-F7DD23B8-B017-4406-BE93-765FD6355A6B Q37169115-569F97C7-6075-4646-AA0B-37C9EBF5130E Q37211273-F24C0C06-958A-4FFE-A115-E55C8814B421 Q37510948-980EE0B5-61AA-4DAE-99C1-F58AE8F541D7 Q37618917-97823E41-F446-434B-A788-655EC8213067 Q37715706-0D46C8C2-9568-43B3-837B-FD7BB9C0D699 Q37899200-858D8E8F-20DB-4DE8-96B2-FBA713642B06 Q38000901-9A8A56A2-CA14-4D7D-9A86-D76DD3F4F392 Q38203323-1198463F-771F-4FF7-9F83-E2D261C91DC7 Q38215116-851A0599-9194-4FF5-B99F-BFF21F2BA3A2 Q43671073-0B849041-4D9D-4C7B-BB9D-06CDB421758D Q43932228-F7E7C353-8D03-49D5-A3AB-8C4E5F9D5575 Q44772306-AE4C0181-6922-433F-9F0E-892A065724FF Q45210269-E842CCB9-13CD-4D4B-85F7-D1397B4A4098 Q47175117-F20E16D7-79BD-49DF-9FC0-DBE4C29AA61B Q48220481-0D0C9233-FA24-451C-B01B-CBD67135B3A2 Q50524845-972253C3-EBBB-494A-BFCD-E5651AB26D16 Q51326495-E1568288-C278-4510-9B24-BFE0CD4FE880

P2860

Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program

http://www.wikidata.org/entity/Q28291559

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Twenty years of unrelated dono ...... National Marrow Donor Program

@ast

Twenty years of unrelated dono ...... National Marrow Donor Program

@en

Twenty years of unrelated dono ...... National Marrow Donor Program

@nl

type

label

Twenty years of unrelated dono ...... National Marrow Donor Program

@ast

Twenty years of unrelated dono ...... National Marrow Donor Program

@en

Twenty years of unrelated dono ...... National Marrow Donor Program

@nl

altLabel

Twenty Years of Unrelated Dono ...... National Marrow Donor Program

@en

prefLabel

Twenty years of unrelated dono ...... National Marrow Donor Program

@ast

Twenty years of unrelated dono ...... National Marrow Donor Program

@en

Twenty years of unrelated dono ...... National Marrow Donor Program

@nl

P1433

Q28291559-2E2E1422-1C18-48CE-B144-A153CA7F2F5B

P1476

Q28291559-79B1A03B-C821-4708-92D4-E1C2CF37DC85

Q28291559-C19DE6CB-942A-4DB6-BB0F-A089D01AA39B

P2093

Q28291559-0407A8F9-06F6-442F-837D-AF145C0518DB

Q28291559-04F5D99B-3A86-4876-BECF-C595999C7B14

Q28291559-08095EBA-A0AC-4713-A608-12B28D027E5F

Q28291559-0F051802-220A-44D2-8D23-522680ECB6AB

Q28291559-0FCC3FFC-48C3-41AF-979F-0CEC28FD1A68

Q28291559-107CBA3E-093E-4158-B914-79B66B02C345

Q28291559-10AB9697-4903-4350-9F7C-CCFBC59815EC

Q28291559-5C8054B8-6107-4400-A6E8-7620355CF14F

Q28291559-668A473C-3E44-4B1F-85F1-4DF9BE3E8ADE

Q28291559-9C2B7110-4798-40D7-A429-E345BF91A934

P304

Q28291559-2164DEA0-D29D-4AC1-B4A4-B67A928F3695

P31

Q28291559-75FF0FB4-F6F3-4F34-AB22-E96685626059

Q28291559-a54d95b1-4ef1-49a8-94ef-db21a8027388

P3181

Q28291559-207C2F24-E4DB-468F-A887-73727A84C0C4

P356

Q28291559-BCFFA4CC-EEEA-4110-A8E1-0AEDE67C615C

P407

Q28291559-6FCED863-009C-45EA-A7D5-0AEB9EFA4EC0

P433

Q28291559-4582D7DB-ACD1-464B-A6AE-27A6D0870861

Q28291559-9D2F0F0B-F805-4809-A8F2-E3A3F69DE218

P478

Q28291559-4C6A982B-FE86-4B62-B860-8124F38C99F7

P577

Q28291559-DF94729F-1D91-4FAE-ABF4-EC7C544A8FBD

P698

Q28291559-33FAD6E9-F0DC-4557-8A1E-7CDF7DB0DA1E

P3181

P356

J.BBMT.2008.06.006

P1433

Biology of Blood and Marrow Transplantation

P1476

Twenty Years of Unrelated Dono ...... National Marrow Donor Program

@en

Twenty years of unrelated dono ...... National Marrow Donor Program

@en

P2093

Charles D Bolan

http://www.w3.org/2001/XMLSchema#string

Charles D. Bolan

http://www.w3.org/2001/XMLSchema#string

Chatchada Karanes

http://www.w3.org/2001/XMLSchema#string

David L Porter

http://www.w3.org/2001/XMLSchema#string

David L. Porter

http://www.w3.org/2001/XMLSchema#string

Dennis L Confer

http://www.w3.org/2001/XMLSchema#string

Dennis L. Confer

http://www.w3.org/2001/XMLSchema#string

Edward Agura

http://www.w3.org/2001/XMLSchema#string

Gene O Nelson

http://www.w3.org/2001/XMLSchema#string

Gene O. Nelson

http://www.w3.org/2001/XMLSchema#string

P304

8-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2872729

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.BBMT.2008.06.006

http://www.w3.org/2001/XMLSchema#string

P407

P433

9 Suppl

http://www.w3.org/2001/XMLSchema#string

9

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18721775

http://www.w3.org/2001/XMLSchema#string